deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT02654860

Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia

Two-part Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia in Patients Scheduled for Hip Replacement Surgery

Sponsor: Cross S.A.

Conditions Phase 1: Pain Management Phase 2: Pain Management
Interventions Hyperbaric Bupivacaine HCl 0.5% Paracetamol 3% Placebo injection containing Saline solution 0.9%
Updated 13 times since 2017 Last updated: Sep 29, 2021 Started: Nov 30, 2016 Primary completion: Feb 28, 2019 Completion: Feb 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Phase 1: Pain Management and Phase 2: Pain Management, this trial is completed. The trial is conducted by Cross S.A. and has accumulated 13 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Apr 2019 · 59 days · monthly snapshot~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Dec 2022 · 13 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1_PHASE2

  5. Nov 2021 — Dec 2022 [monthly]

    Completed PHASE1_PHASE2

▶ Show 8 earlier versions

  1. Sep 2021 — Nov 2021 [monthly]

    Completed PHASE1_PHASE2

  2. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE1_PHASE2

  3. Apr 2019 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Status: Recruiting → Completed

  4. Feb 2019 — Apr 2019 [monthly]

    Recruiting PHASE1_PHASE2

  5. Dec 2018 — Feb 2019 [monthly]

    Recruiting PHASE1_PHASE2

  6. Jun 2018 — Dec 2018 [monthly]

    Recruiting PHASE1_PHASE2

  7. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting · Phase: PHASE2 → PHASE1_PHASE2

  8. Jan 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cross S.A.
  • Sintetica SA
Data source: Sintetica SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations